A
$ Value
$0
Shares
25,331
Price
$0
Filed
Oct 6
Insider
Name
Louie Ngar Yee
Title
—
CIK
0001913264
Roles
Director
Transaction Details
Transaction Date
2025-10-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,331
Footnotes
The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Filing Info
Louie Ngar Yee's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MAIA | A | $0 |
| 2025-12-31 | MAIA | A | $0 |
| 2025-12-22 | MAIA | ▲ | $100K |
| 2025-12-22 | MAIA | ▲ | $111K ★ |
| 2025-10-02 | MAIA | A | $0 |
| 2025-06-30 | MAIA | A | $0 |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |